M
Mosaic Biosciences
Developer of synthetic extracellular materials used to support natural tissue regeneration
About Mosaic Biosciences
Mosaic Biosciences is a cutting-edge biotechnology startup specializing in the discovery and development of therapeutic antibodies and proteins. The company leverages its proprietary Phage and Yeast Display libraries to accelerate the identification, characterization, and optimization of these therapeutic agents. Essentially, Mosaic Biosciences transforms initial concepts into viable drug candidates through its comprehensive discovery capabilities and a highly skilled multidisciplinary team.
The company serves a diverse range of clients, including startup companies, innovation or venture firms, biopharmaceutical companies, development-stage biopharmaceutical firms, and academic groups. These clients typically seek to accelerate their research, validate new ideas, or advance therapeutic programs to a more mature stage.
Operating in the biopharmaceutical market, Mosaic Biosciences employs a business model centered around partnerships. It collaborates with clients to advance antibody discovery projects from the initial concept stage to the identification of a preclinical candidate with validated pharmacology and drug-like properties. The company makes money through these partnerships by providing access to its advanced technology, expert scientists, and data-driven approach.
Mosaic Biosciences also offers a range of analytical services to assess the quality of materials produced internally. These services include biophysical, biochemical, and bioanalytical techniques such as High-Performance Liquid Chromatography (HPLC), interferometry, and plate-based methods to measure purity and other critical parameters.
In summary, Mosaic Biosciences is a dynamic player in the biotech industry, providing end-to-end solutions for the discovery and development of therapeutic antibodies and proteins. Its innovative approach and robust technology platform make it a valuable partner for various stakeholders in the biopharmaceutical ecosystem.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2009
- Headquarters
- Boulder, United States
- Employees
- 47
- Open positions
- None listed
- Dealroom signal
- 63.5/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, proteomics, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jun 2022 | $11M | $46M | Dan Mitchell · Telegraph Hill Partners | ↗ |
| GRANT✓Other financing | May 2021 | $242K | — | Colorado Office of Economic Development and International Trade | ↗ |
Growth signals
Latest recorded traffic for Mosaic Biosciences is 2.5K monthly website visits, down 34.2% over the last three months. Mosaic Biosciences's team declined 11.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Mosaic Biosciences in the Boulder ecosystem
The Mosaic Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Colorado Office of Economic Development and International Trade
Series A5 investors entered at this stage
- MVMorgenthaler Ventures
- HVHealthCare Ventures
- HVHigh Country Venture
Telegraph Hill Partners
Dan Mitchell
Other known investors2 additional known investors
University of Colorado Boulder
Lightstone Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Mosaic Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Mosaic Biosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










